The dvm360® oncology page is a comprehensive resource for clinical news and insights on the latest in veterinary oncology. This page consists of videos, interviews, articles, podcasts, and research on the advancements and developments of therapies for oncology, and more.
May 17th 2024
Rachel Venable, DVM, MS, DACVIM (Oncology) presented oncology updates to general practitioners at Fetch Nashville
Definitive diagnosis of thyroid malignancy
September 1st 2008Thyroid tumors are relatively uncommon in dogs, accounting for only 1 percent to 4 percent of all tumors. The majority of diagnosed thyroid tumors in dogs are malignant, because adenomas are clinically silent and found incidentally on necropsy.
Practical Matters: Importance of thoracic radiography in patients with cancer
August 1st 2008One might be tempted to say that a tumor that rarely spreads to the lungs does not require thoracic radiography, but I cannot think of any instance in a cancer patient's work-up in which looking at the thorax is unnecessary.
WSU marrow-transplant program offers improved option against canine lymphoma
July 1st 2008Pullman, Wash. - In an effort to make canine bone-marrow transplants more commonplace for dogs, Washington State University's (WSU) College of Veterinary Medicine is preparing to open its own transplant center at its veterinary teaching hospital.
Clinical Exposures: Canine transmissible venereal tumor: The cytologic clues
June 1st 2008A 3-year-old castrated male Labrador retriever with a history of blood dripping from its penis was referred to the Foster Hospital for Small Animals at the Cummings School of Veterinary Medicine at Tufts University.
Texas A&M to construct cancer center
May 2nd 2008College Station, Texas - 5/2/2008 - Texas A&M University's veterinary college received approval to build a veterinary imaging and cancer research center. Plans for the $4.5-million project include an 8,000-square-foot building for small-animal and equine patients.
Oral melanoma: Improving dogs' survival
April 1st 2008It is not often that one is able to bear witness to a sea change. The veterinary community has, in my opinion, seen one with the development of the melanoma vaccine. This unique form of therapy, a DNA-based vaccine, would justify my opinion, but the successful collaboration between veterinary oncologists, human oncologists and the pharmaceutical industry also serve to mark this event as extraordinary.
A challenging case: Glucagonoma-associated superficial necrolytic dermatitis in a dog
March 1st 2008An 8-year-old 46.3-lb (21-kg) female spayed mixed-breed dog was referred to the Purdue University Veterinary Teaching Hospital for evaluation of lethargy, inappetence, weight loss, and alopecia of several months' duration.